Navigation Links
Premier Wen Visits Asymchem's Tianjin Facility
Date:11/10/2011

TIANJIN, China, Nov. 10, 2011 /PRNewswire/ -- Asymchem Life Science (Tianjin) Co. Ltd., a leading research-based contract manufacturer of intermediates, API's and Drug Products for the pharmaceutical industry with sites in the U.S. and China, was pleased to receive a visit from Premier Wen Jiabao at its GMP R&D and manufacturing facility on the afternoon of October 24th, 2011. Premier Wen, a member of the Standing Committee of the Political Bureau of the CPC Central Committee and Premier of the State Council, visited Asymchem during his investigative trip to observe the development of Tianjin Binhai New Area where Asymchem is based. Premier Wen was accompanied by Mr. Zhang Gaoli, the Tianjin Municipal Committee Secretary.

During his visit, Premier Wen praised the CEO of Asymchem, Dr. Hao Hong, for Asymchem's growth. Asymchem has risen from a company with $250,000 USD in registered capital to one with $65 million USD in manufacturing output. Dr. Hong states, "Premier Wen spoke highly of Asymchem's innovation and its presence as a leading Chinese pharmaceutical company, which has the power to attract international talents."

Premier Wen also visited the Analysis and Testing Center and the process R&D center at Asymchem, commenting positively on Asymchem's dual focus on internationally advanced facilities and the involvement of high-tech talents. Dr. Hong adds, "Through the pursuance of high-tech innovation, Asymchem will continue to contribute to the development of the biopharmaceutical and strategically important new industries in the Tianjin Binhai New Area and throughout the whole of China."

With a diverse range of capabilities ranging from the synthesis of sophisticated organic chemicals in the lab to commercial scale production of API's, Asymchem offers a comprehensive list of services for pharmaceutical customers. For more information on Asymchem, please visit our website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Life Science (Tianjin) Co. Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin Becomes Premier Founding Sponsor of RMECs New Osteobiologics Registry
2. BioNeutral to Premier its EPA-Approved Ygiene® 206 Hospital-Grade Disinfectant at the Annual 2011 APIC Conference, While Community Health of South Florida Begins Product Review
3. Mathematics and Biochemistry Research Earn Top Prize at Nations Premier High School Science Competition
4. Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept. 29
5. Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
6. Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners
7. Mexico Premiere for Money-Saving Pharma Leak Testing Equipment
8. Chinas Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
9. Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance
10. Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nations Premier High School Science Competition
11. Premier Research Achieves Double-Digit Growth in Functional Sourcing for the Third Straight Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... the FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, ... require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc ... to client demand KbioBox developed a sophisticated “3 click” gene dditing off target ... from KBioBox’s new website, https://www.kbiobox.com/ and powered by the company’s ...
(Date:12/8/2016)... 8, 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... on developing and commercializing products to treat rare ... announced today the long-term follow-up data from its ... first-in-class Innate Defense Regulator (IDR), in the treatment ... cancer patients undergoing chemoradiation therapy (CRT).  The additional ...
(Date:12/8/2016)... Korea , Dec. 8, 2016 Eutilex ... $21 billion KRW (US $18.9M) Series A financing. This ... Investment, G.N. Tech Venture and SNU Bio Angel. This ... to 30.5 billion KRW (US $27.7M) since its founding ... Eutilex to bolster the development and commercialization of its ...
Breaking Biology Technology:
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
(Date:11/15/2016)... Research and Markets has announced the addition of the ... their offering. ... The global bioinformatics market ... 6.21 Billion in 2016, growing at a CAGR of 21.1% during ... is driven by the growing demand for nucleic acid and protein ...
(Date:6/22/2016)... -- The American College of Medical Genetics and Genomics was once ... one of the fastest-growing trade shows during the Fastest 50 ... Las Vegas . Winners ... each of the following categories: net square feet of paid ... The 2015 ACMG Annual Meeting was ranked 23 out of ...
Breaking Biology News(10 mins):